EMA’s New Draft Guideline On Good Pharmacogenomic Practice - Implications For Personalized Medicine
By EsqSocial Corporation 20/06/16
Embracing personalized medicine, the European Medicines Agency (EMA) released a draft guidance document titled Draft Guideline on Good Pharmacogenomic Practice (“Guidance”) on good pharmacogenomic practice with the stated goal of developing and...
By: Foley & Lardner LLP